Enroll in the Study | Anifrolumab Breastfeeding Study

Contact request form

Complete this form and a study team member will contact you with more information about participating in the Study.

* marks required field.

I authorize the Anifrolumab Breastfeeding Study to contact me and/or leave a message for me at these numbers or to contact me via email at the address listed below. I agree to the study referencing the Anifrolumab Breastfeeding Study in messages or emails.

Potential Participant Name*

Email*

Street Address*

City City

State / Province* State / Province*

Zip / Postal Code Zip / Postal Code

Primary Phone Number*

Alternate Phone Number

The study is open from 8:30 AM - 5:00 PM EST.

Please identify the best time for contact.

Please identify the best day for contact.

Monday

Tuesday

Wednesday

Thursday

Friday

Privacy Statement:

Pharmaceutical Product Development, LLC. (PPD) respects your privacy and understands that it is important to you. The information you provide on this form will be used to contact you for the purposes of assessing your eligibility to participate in the Anifrolumab Breastfeeding Study. This information will be held by PPD and not shared with the study sponsor (AstraZeneca) or any other third party without your permission. In the event you choose not to enroll, the study team will request permission to share your contact information with AstraZeneca. In order for them to contact you for safety follow up about your pregnancy. If you do not provide permission, and do not enroll in the Study your contact details will be deleted.

Are you eligible to enroll?

Thank you for confirming your eligibility to enroll!

Contact request form